PDT Partners LLC boosted its stake in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 152.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 167,232 shares of the company's stock after acquiring an additional 101,011 shares during the quarter. PDT Partners LLC owned about 0.38% of Vital Farms worth $5,096,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in VITL. Dimensional Fund Advisors LP lifted its position in Vital Farms by 7.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 901,537 shares of the company's stock worth $33,978,000 after acquiring an additional 59,397 shares during the period. MetLife Investment Management LLC raised its stake in shares of Vital Farms by 6.2% during the 4th quarter. MetLife Investment Management LLC now owns 20,035 shares of the company's stock worth $755,000 after buying an additional 1,175 shares in the last quarter. Stifel Financial Corp raised its stake in shares of Vital Farms by 6.8% during the 4th quarter. Stifel Financial Corp now owns 8,117 shares of the company's stock worth $306,000 after buying an additional 518 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Vital Farms during the 4th quarter worth approximately $291,000. Finally, Northern Trust Corp raised its stake in shares of Vital Farms by 15.0% during the 4th quarter. Northern Trust Corp now owns 335,117 shares of the company's stock worth $12,631,000 after buying an additional 43,804 shares in the last quarter. 98.59% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Vital Farms
In related news, CEO Russell Diez-Canseco sold 16,700 shares of Vital Farms stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $46.11, for a total value of $770,037.00. Following the transaction, the chief executive officer owned 702,476 shares in the company, valued at approximately $32,391,168.36. This trade represents a 2.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Matthew Ohayer sold 145,000 shares of Vital Farms stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $51.98, for a total value of $7,537,100.00. Following the completion of the transaction, the insider owned 6,582,070 shares in the company, valued at $342,135,998.60. The trade was a 2.16% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 348,901 shares of company stock valued at $16,791,152. 21.30% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
VITL has been the subject of a number of analyst reports. Mizuho increased their target price on Vital Farms from $45.00 to $53.00 and gave the stock an "outperform" rating in a research note on Monday, August 11th. Lake Street Capital set a $60.00 target price on Vital Farms and gave the stock a "buy" rating in a research note on Friday, August 8th. Stifel Nicolaus increased their target price on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Telsey Advisory Group increased their target price on Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Finally, DA Davidson increased their target price on Vital Farms from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Monday, August 11th. Eleven analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $49.80.
Check Out Our Latest Stock Analysis on Vital Farms
Vital Farms Price Performance
NASDAQ VITL traded up $2.33 during mid-day trading on Thursday, hitting $51.60. The stock had a trading volume of 1,455,501 shares, compared to its average volume of 1,008,092. Vital Farms, Inc. has a 52-week low of $27.91 and a 52-week high of $53.13. The company has a market cap of $2.31 billion, a price-to-earnings ratio of 46.07 and a beta of 0.94. The company has a 50 day simple moving average of $42.35 and a 200 day simple moving average of $36.20. The company has a quick ratio of 2.10, a current ratio of 2.48 and a debt-to-equity ratio of 0.02.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.09. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%.The company had revenue of $184.77 million during the quarter, compared to the consensus estimate of $170.28 million. During the same quarter last year, the business posted $0.36 earnings per share. Vital Farms's revenue was up 25.4% compared to the same quarter last year. Vital Farms has set its FY 2025 guidance at EPS. Equities analysts forecast that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.
Vital Farms Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.